A Mount Sinai team showed that the same leukemia mutation behaves differently depending on when it arises during development.

The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer research in mouse models with an immune system that is as natural as possible – ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

In cooperation with universities, the Center of Estonian Rural Research and Knowledge (METK) is leading a project aimed at ...

SEOUL, South Korea, Nov. 19, 2025 /PRNewswire/ -- ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent and Trademark Office has ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a once-and-done treatment paradigm for diseases with ...

JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing ...

Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the ...